NIV-001
Motor recovery in chronic stroke (6+ months post-event)
Phase 2Active
Key Facts
Indication
Motor recovery in chronic stroke (6+ months post-event)
Phase
Phase 2
Status
Active
Company
About Neuro-Innovators
Neuro-Innovators is pioneering a de-risked, capital-efficient approach to treating neurological disorders by developing combination therapies from existing, brain-penetrant FDA-approved drugs. Its lead asset, NIV-001, targets motor recovery in chronic stroke, a significant unmet need with no current standard of care. The company's strategy is built on a proprietary screening platform and a polypharmacology rationale, aiming to accelerate development timelines and create barriers to entry. Led by a veteran team of neurotech executives and scientists, Neuro-Innovators is positioned to advance its clinical pipeline while expanding its platform to other indications.
View full company profile